Overview of the Guidance for Industry:
Electronic Drug Registration and Listing
New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment
Celebrating 40 Years:
Looking for files or recordings from past events?
Subscribe to Our Update Emails
The best way to stay up-to-date with information from FDA and CDER
